metronidazole has been researched along with pentamidine in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (29.17) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (16.67) | 29.6817 |
2010's | 13 (54.17) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Argotte-Ramos, R; Cedillo-Rivera, R; Chan-Bacab, MJ; Guerrero-Alvarez, J; Hernández-Núñez, E; León-Rivera, I; Moo-Puc, R; Navarrete-Vázquez, G; Rodríguez-Gutiérrez, Mdel C; Torres-Gómez, H | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Castillo, R; Hernández-Campos, A; Hernández-Hernández, M; Hernández-Luis, F; Navarrete-Vázquez, G; Soria-Arteche, O; Yépez-Mulia, L | 1 |
Fairlamb, AH; Oza, SL; Patterson, S; Read, KD; Sokolova, AY; Wyllie, S | 1 |
Cedillo-Rivera, R; Chan-Bacab, MJ; Estrada-Soto, S; Guerrero-Alvarez, J; León-Rivera, I; Mirón-López, G; Molina-Salinas, GM; Moo-Puc, R; Nava-Zuazo, C; Navarrete-Vazquez, G; Said-Fernández, S | 1 |
Argotte-Ramos, R; Cedillo-Rivera, R; Chan-Bacab, MJ; Chávez-Silva, F; Hernández-Nuñez, E; Moo-Puc, R; Navarrete-Vazquez, G; Rodríguez-Gutiérrez, Mdel C | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chan-Bacab, MJ; Chávez-Silva, F; Díaz-Coutiño, D; Hernández-Núñez, E; Moo-Puc, R; Moreno-Díaz, H; Nava-Zuazo, C; Navarrete-Vázquez, G; Ortega-Morales, BO | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Ahmad, A; Biersack, B; Ersfeld, K; Koko, WS; Lockhauserbäumer, J; Mahal, K; Padhye, S; Pradhan, R; Sarkar, FH; Schmitt, F; Schobert, R; Starz, K | 1 |
Argüello-Garcia, R; Barbosa-Cabrera, E; Chan-Bacab, MJ; Colín-Lozano, B; Hernández-Núñez, E; León-Rivera, I; López-Guerrero, V; Moo-Puc, R; Navarrete-Vázquez, G; Ortega-Morales, BO; Scior, T | 1 |
Ang, CW; Avery, VM; Blaskovich, MAT; Butler, MS; Cooper, MA; Debnath, A; Hahn, HJ; Jarrad, AM; Jones, AJ; Karoli, T; Pelingon, R; Sykes, ML; Tan, L; West, NP; Woods, K | 1 |
Azas, N; Basmaciyan, L; Belle Mbou, V; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, É; Casanova, M; Castera-Ducros, C; Cohen, A; Courtioux, B; Fairlamb, AH; Fersing, C; Hutter, S; Laget, M; Milne, R; Pedron, J; Piednoel, M; Primas, N; Rathelot, P; Since, M; Sournia-Saquet, A; Valentin, A; Vanelle, P; Verhaeghe, P; Wyllie, S | 1 |
Smit, AM; van der Kaay, HJ | 1 |
Gill, F; Miller, LH; Neva, FA | 1 |
Lefrock, JL; Smith, BR | 1 |
Bartlett, MS; Eichholtz, R; Smith, JW | 1 |
Keithly, JS; Langreth, SG | 1 |
Hosseini, J; Swan, JC; Zierdt, CH | 1 |
Barrett-Connor, E | 1 |
Hwang, SJ; Maede, Y; Murakami, M; Nakamura, K; Ohta, H; Sasaki, N; Takiguchi, M; Wickramasekara Rajapakshage, BK; Yamasaki, M | 1 |
2 review(s) available for metronidazole and pentamidine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Drugs for the treatment of parasitic infection.
Topics: Antimony; Bithionol; Chloroquine; Diethylcarbamazine; Humans; Mebendazole; Melarsoprol; Metronidazole; Niclosamide; Niridazole; Oxamniquine; Parasitic Diseases; Pentamidine; Piperazines; Primaquine; Pyrantel Pamoate; Pyrimethamine; Suramin; Thiabendazole; Trichlorfon | 1982 |
22 other study(ies) available for metronidazole and pentamidine
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Design, synthesis and in vitro antiprotozoal activity of benzimidazole-pentamidine hybrids.
Topics: Animals; Antiprotozoal Agents; Benzimidazoles; Drug Design; Entamoeba histolytica; Giardia lamblia; Inhibitory Concentration 50; Leishmania mexicana; Metronidazole; Molecular Structure; Parasitic Sensitivity Tests; Pentamidine; Plasmodium berghei; Structure-Activity Relationship; Trichomonas vaginalis | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Synthesis and biological activity of 2-(trifluoromethyl)-1H-benzimidazole derivatives against some protozoa and Trichinella spiralis.
Topics: Animals; Antiprotozoal Agents; Benzimidazoles; Inhibitory Concentration 50; Larva; Mice; Trichinella spiralis | 2010 |
Cross-resistance to nitro drugs and implications for treatment of human African trypanosomiasis.
Topics: Animals; Cell Line; Drug Resistance; Eflornithine; Humans; Mice; Nifurtimox; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 2010 |
Design, synthesis, and in vitro antiprotozoal, antimycobacterial activities of N-{2-[(7-chloroquinolin-4-yl)amino]ethyl}ureas.
Topics: Anti-Bacterial Agents; Antiprotozoal Agents; Drug Design; Giardia lamblia; Humans; Leishmania mexicana; Mycobacterium tuberculosis; Quinolines; Structure-Activity Relationship; Urea | 2010 |
Synthesis of benzologues of Nitazoxanide and Tizoxanide: a comparative study of their in vitro broad-spectrum antiprotozoal activity.
Topics: Antiprotozoal Agents; Giardia; Molecular Structure; Nitro Compounds; Plasmodium; Thiazoles; Trichomonas vaginalis | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
2-acylamino-5-nitro-1,3-thiazoles: preparation and in vitro bioevaluation against four neglected protozoan parasites.
Topics: Animals; Antiprotozoal Agents; Drug Design; Humans; Protozoan Infections; Thiazoles | 2014 |
Improved anticancer and antiparasitic activity of new lawsone Mannich bases.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cytoskeleton; Drug Design; Entamoeba histolytica; Humans; Inhibitory Concentration 50; Mannich Bases; Naphthoquinones; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei | 2017 |
Synthesis, in vitro and in vivo giardicidal activity of nitrothiazole-NSAID chimeras displaying broad antiprotozoal spectrum.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antiprotozoal Agents; Drug Design; Female; Giardia lamblia; Giardiasis; Humans; Leishmania; Mice; Nitro Compounds; Protozoan Infections; Thiazoles; Trichomonas vaginalis; Trypanosoma cruzi | 2017 |
Design, Synthesis, and Biological Evaluation of 2-Nitroimidazopyrazin-one/-es with Antitubercular and Antiparasitic Activity.
Topics: Animals; Antiparasitic Agents; Antitubercular Agents; Caco-2 Cells; Drug Design; Drug Evaluation, Preclinical; Drug Stability; Entamoeba histolytica; Giardia lamblia; Humans; Mice; Microbial Sensitivity Tests; Microsomes, Liver; Nitroimidazoles; Structure-Activity Relationship | 2018 |
Nongenotoxic 3-Nitroimidazo[1,2-
Topics: | 2019 |
Cutaneous leishmaniasis [proceedings].
Topics: Antimony; Antimony Sodium Gluconate; Humans; Leishmaniasis; Leishmaniasis, Mucocutaneous; Metronidazole; Pentamidine | 1977 |
Failure of chloroquine in human babesiosis (Babesia microti): case report and chemotherapeutic trials in hamsters.
Topics: Animals; Babesiosis; Benzamidines; Chloroquine; Cricetinae; Drug Resistance; Humans; Male; Metronidazole; Middle Aged; Minocycline; Pentamidine; Pyrimethamine; Recurrence; Sulfadiazine; Tetracycline; Time Factors | 1978 |
Drugs for protozoan infections.
Topics: Antimalarials; Antimony Sodium Gluconate; Antiprotozoal Agents; Humans; Iodoquinol; Melarsoprol; Metronidazole; Nifurtimox; Pentamidine; Protozoan Infections; Suramin | 1987 |
Antimicrobial susceptibility of Pneumocystis carinii in culture.
Topics: Amphotericin B; Animals; Anti-Infective Agents; Cell Line; Chloroquine; Culture Media; Drug Combinations; Humans; Metronidazole; Miconazole; Pentamidine; Pneumocystis; Rats; Rats, Inbred Strains; Sulfamethoxazole; Time Factors; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1985 |
Inefficacy of metronidazole in experimental infections of Leishmania donovani, L. mexicana, and Trypanosoma brucei brucei.
Topics: Animals; Antimony Sodium Gluconate; Cricetinae; Leishmaniasis; Leishmaniasis, Visceral; Mesocricetus; Metronidazole; Mice; Microscopy, Electron; Nose; Pentamidine; Trypanosoma brucei brucei; Trypanosomiasis, African | 1983 |
In vitro response of Blastocystis hominis to antiprotozoal drugs.
Topics: Animals; Antiprotozoal Agents; Emetine; Eukaryota; Furans; Furazolidone; Metronidazole; Paromomycin; Pentamidine; Quinolines; Sulfamethoxazole; Trimethoprim | 1983 |
Development and characterization of a strain of Babesia gibsoni resistant to diminazene aceturate in vitro.
Topics: Animals; Antiprotozoal Agents; Babesia; Babesiosis; Cell Division; Clindamycin; Diminazene; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Doxycycline; Drug Resistance; Erythrocytes; Metronidazole; Pentamidine | 2010 |